Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Evans DG et al. – Both phase 0 and phase II NF2 trials are near–term options for NF2 clinical trials. The number of NF2 patients in the population remains limited, and successful recruitment will require ongoing collaboration efforts between NF2 clinics.

Related Articles

Qigong for type 2 diabetes care: A systematic review
Complementary Therapies in Medicine, 10/30/09    Relevance Score: 69%

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes
Vascular Health and Risk Management, 10/29/09    Relevance Score: 69%

Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations
Acta Diabetologia, 10/29/09    Relevance Score: 69%

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09    Relevance Score: 69%

Maternal and Fetal Outcome in Women with Type 2 Versus Type 1 Diabetes Mellitus: A Systematic Review and Metaanalysis
Journal of Clinical Endocrinology and Metabolism, 10/14/09    Relevance Score: 69%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address